Table 1 Demographic characteristics and outcomes of two groups
Characteristic | PQ high dose (N = 25) n (%) or Mean ± SD | PQ low dose (N = 25) n (%) or Mean ± SD | p-value |
|---|---|---|---|
Gender | |||
Male | 23 (92) | 22 (88) | 0.63 |
Female | 2 (8) | 3 (12) | |
Age, years | 42.0 ± 16.0 | 40.0 ± 15.0 | 0.34 |
Body weight, kg | 67.9 ± 14.1 | 64.6 ± 13.7 | 0.40 |
Body mass index, kg/m2 | 25.0 ± 4.0 | 24.6 ± 5.2 | 0.43 |
Past h/o malaria | 6 (24) | 11 (44) | 0.13 |
Pre-morbidities | |||
Diabetes mellitus | 2 (8) | 4 (16) | 0.38 |
Hypertension | 2 (8) | 5 (20) | 0.22 |
Chronic kidney disease | 0 | 1 (4) | 0.31 |
Heart disease | 0 | 2 (8) | 0.15 |
Severity | |||
Non-severe | 24 (96) | 24 (96) | 1.00 |
Severe | 1 (4) | 1 (4) | |
Schizonticidal treatment | |||
Chloroquine | 20 (80) | 19 (76) | 0.73 |
Artemisinin combination therapy | 5 (20) | 6 (24) | |
Use of personal protective measures during follow-up | |||
Mosquito repellents | 16 (64) | 18 (72) | 0.54 |
Regular bed net | 3 (12) | 2 (8) | 0.63 |
Study outcome | |||
Recurrence | 2 (4) | 2 (4) | – |